Dextech Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	10.12	14.71	19.04	25.24	35.47	3.46
Cash & Short-Term Investments	10.12	14.71	19.04	25.24	35.47	3.46
Cash Growth	-35.14%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Other Receivables	-	0.09	0.13	0.11	0.2	0.03
Receivables	0.68	0.09	0.13	0.11	0.2	0.03
Other Current Assets	-	0.38	0.5	0.47	0.35	0.26
Total Current Assets	10.8	15.18	19.68	25.82	36.02	3.75
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	9.88	0.25	0.25	0.25	0.39	0.54
Long-Term Deferred Charges	-	9.67	10.66	8.97	3.18	2.94
Total Assets	20.68	25.1	30.59	35.03	39.59	7.23
Accounts Payable	-	0.13	0.28	0.15	0.25	0.04
Accrued Expenses	-	0.18	0.69	0.55	0.43	0.15
Other Current Liabilities	0.54	0.02	0.01	0.02	0.03	0.03
Total Current Liabilities	0.54	0.34	0.98	0.72	0.71	0.22
Total Liabilities	0.54	0.34	0.98	0.72	0.71	0.22
Common Stock	20.14	0.83	0.83	0.83	0.83	0.67
Additional Paid-In Capital	-	105.2	105.2	105.2	105.2	68.22
Retained Earnings	-	-81.26	-76.42	-71.71	-67.15	-61.88
Shareholders' Equity	20.14	24.76	29.61	34.31	38.88	7.02
Total Liabilities & Equity	20.68	25.1	30.59	35.03	39.59	7.23
Net Cash (Debt)	10.12	14.71	19.04	25.24	35.47	3.46
Net Cash Growth	-35.14%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Net Cash Per Share	0.54	0.79	1.01	1.37	2.09	0.23
Filing Date Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Total Common Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Working Capital	10.26	14.85	18.7	25.1	35.31	3.54
Book Value Per Share	1.09	1.34	1.60	1.86	2.10	0.47
Tangible Book Value	10.26	24.51	29.36	34.07	38.49	6.47
Tangible Book Value Per Share	0.56	1.33	1.59	1.84	2.08	0.43